Bennet, Tillis, Hyde-Smith Introduce Bipartisan Legislation to Rebuild the Strategic National Stockpile, Strengthen Domestic PPE Manufacturing

Denver – Colorado U.S. Senator Michael Bennet and U.S. Senators Thom Tillis (R-N.C.) and Cindy Hyde-Smith (R-Miss.) introduced bipartisan legislation to improve the Strategic National Stockpile and strengthen the domestic manufacturing of supplies, like Personal Protective Equipment (PPE), to ensure the United States is better prepared for future public health emergencies. 

When the Coronavirus Disease 2019 (COVID-19) pandemic began in the United States, health care workers were given few supplies and equipment from the Strategic National Stockpile, much of which was expired and outdated. The lack of critical medical supplies across the existing domestic supply chain forced the United States to rely on China and other nations to manufacture this equipment, making it more difficult for the United States to respond. The Medical Supplies for Pandemics Act of 2020 would incent manufacturers of critical supplies to strengthen their supply chains and establish domestic reserves of critical medical supplies for future public health emergencies. 

“We must improve our public health infrastructure based on the lessons learned from this COVID-19 pandemic and ensure the Strategic National Stockpile is well equipped to support a response to a large-scale crisis,” said Bennet. “This bipartisan bill will help us ramp up America’s manufacturing and distribution of critical supplies like Personal Protective Equipment so we are better prepared for the next national emergency and not beholden to countries like China.”    

“When the COVID-19 outbreak began, the Chinese government’s effort to cover up the severity of COVID-19 while stockpiling critical medical supplies hindered the United States’ ability to respond to the pandemic and made clear that our country is far too reliant on foreign nations to deal with future pandemics,” said Tillis. “The bipartisan Medical Supplies for Pandemic Act will make much-needed reforms to strengthen our ability to respond to future disasters and provide frontline workers the resources they need during public health emergencies.”  

“The coronavirus pandemic exposed risks in not maintaining a stronger U.S.-based infrastructure for critical medical supplies,” said Hyde-Smith. “This legislation would establish a framework to improve and renew the Strategic National Stockpile so that the health and wellbeing of Americans isn’t unfairly jeopardized by bad actors like China.” 

Specifically, the Medical Supplies for Pandemics Act of 2020 would authorize $500 million annually through fiscal year 2023 to implement a supply chain flexibility manufacturing program to:

  • Create incentives for the domestic manufacturer of medical supplies to enhance supply chain elasticity;
  • Establish and maintain domestic reserves of critical medical supplies like personal protective equipment and diagnostic tests; and
  • Work with distributors of medical supplies to manage domestic reserves held by the Strategic National Stockpile by refreshing and replenishing supply stocks. 

The bill text is available HERE.